Use of Metabonomics and Body Imaging for Metabolic Health Assessment

May 12, 2025 updated by: Société des Produits Nestlé (SPN)
The aim of this pilot study is to develop at Nestlé Research Center a database of metabolic profiles, body composition, food habits and physical activities on a large cohort of human volunteers. Analysis of collected data will serve to measure the variability of the data and to assess the potential of combining metabonomics with imaging techniques (iDXA) to monitor the metabolic and physiologic effects of foods.

Study Overview

Status

Completed

Conditions

Detailed Description

The study will be carried out at the metabolic unit of the Nestlé Research Center (Lausanne). A large cohort of subjects will be recruited among Nestlé employees. Body composition will be determined by iDXA (Dual-energy X-ray absorptiometry) and basal metabolism will be measured by metabonomic analysis of urine and plasma samples.

Individual food habits and physical activities will be assessed by questionnaires.

The clinical protocol plans also the measurement of energy expenditure (EE) by indirect calorimetry on a subset of twenty subjects. These EE data will be used to validate iDXA outcomes for resting energy expenditure.

The volunteers can participate a second time to this study in the case they would like to control the evolution of their body composition and metabolism after a period of dietary regime or physical training. In such a case, a minimum period of two months between the visits is required.

After two days of dietary restrictions, the volunteers will come in the morning at the metabolic unit at fasting state, for urine and blood sampling. The metabolism of some foods can bias the metabonomic analyses. Therefore, the consumption of alcoholic beverages, fish meals, liquorice, grapefruit, power drinks and bars, spices, mineral supplements, soft drinks, chocolate, coffee and tea limited to 2 cups per day, are not allowed during two days preceding the visit. In addition, the intake of pain-killers or antiinflammatory drugs is forbidden during the two days before the sampling of urine and blood because their metabolism alters the metabolic profiles of blood and urine.

Antibiotics alter gut microflora, for which the activity represents an important contributor to the urinary metabolic profile. In order to preserve gut microflora-related metabolic information, we recommend a minimum period of one month between the end of any antibiotic therapy and the visit at the metabolic unit.

On the visit day, subjects will come fasting at the metabolic unit, where they will have to:

  • Answer some medical questions during an interview with the doctor in charge of the study
  • Fill in two questionnaires on food habits and physical activities. A dietician of the CHUV will visit you at NRC to ask you for some questions relative to your food habits. This is to validate the new questionnaire you filled in
  • Give a sample of urine
  • Undergo iDXA scan (2 consecutive measures will be run at each of the two visits, in order to assess the intra-individual variability of the results) and measure of the state of hydration by bioimpedance The analysis of plasma samples is recommended to complete the metabonomic analysis. However, the blood sampling will be freely decided by each participant. The protocol plans also to perform measurements of resting energy expenditure by indirect calorimetry on a subset of twenty subjects.

Study Type

Observational

Enrollment (Actual)

225

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Studied population: 100-300 subjects, men and women selected out of Nestlé employees

Description

Inclusion Criteria:

All subjects must comply with all the following inclusion criteria:

  • Having respected dietary restrictions 2 days before the visit
  • Having obtained his/her or his/her legal representative's informed consent

Exclusion Criteria:

Subjects representing one or more of the following criteria are excluded from participation in the study:

  • Pregnancy as per precaution principal to avoid risks linked to X-ray exposure
  • Any pathology (infectious or other) having required an antibiotic therapy within

    1 month prior to the beginning of the study

  • Any therapy (contraception apart) within the 2 days before the visit day
  • Subject who cannot be expected to comply with measures
  • Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lean, fat, and bone mass (Measure of full body composition in lean, fat, and bone mass)
Time Frame: change of body composition after a period of 2 months following baseline
Measure of full body composition in lean, fat, and bone mass
change of body composition after a period of 2 months following baseline
Screening of metabolites in plasma in fasting condition
Time Frame: Change of plasma metabolites after a period of 2 months post baseline
Measure of plasma metabolites by Nuclear Magnetic Resonance spectroscopy and Mass Spectrometry
Change of plasma metabolites after a period of 2 months post baseline
Screening of urine metabolites in fasting condition
Time Frame: Change of urine metabolites after a period of 2 months post baseline
Measure of urine metabolites by Nuclear Magnetic Resonance spectroscopy and Mass Spectrometry
Change of urine metabolites after a period of 2 months post baseline
Food habits (Measure of food habits based on Food Frequency Questionnaires)
Time Frame: Change of food habits after a period of 2 months post baseline
Measure of food habits based on Food Frequency Questionnaires
Change of food habits after a period of 2 months post baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Serge Rezzi, PhD, Nestlé Institute of Health Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2008

Primary Completion (Actual)

April 1, 2009

Study Completion (Actual)

October 1, 2010

Study Registration Dates

First Submitted

February 4, 2015

First Submitted That Met QC Criteria

February 20, 2015

First Posted (Estimated)

February 26, 2015

Study Record Updates

Last Update Posted (Actual)

May 14, 2025

Last Update Submitted That Met QC Criteria

May 12, 2025

Last Verified

February 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 08.03.MET

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Full body composition and of plasma and urine metabolites

Subscribe